Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y1 - PP > Lecture 19 -Basic Molecular Pathology > Flashcards

Lecture 19 -Basic Molecular Pathology Flashcards

1
Q

How can a tumour biopsy be obtained for a central lung tumour?

How can a tumour biopsy be obtained for a peripheral lung tumour?

A

Central = Brochoscope

Peripheral = anaesthetic + needle through chest guided by ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of scan can be given to se if a malignancy has spread

A

PET scan
Positron Emission Tomography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is gland forming cancer?

A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you confirm diagnosis of Non Small Cell Carcinoma?

A

Molecular markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are lung molecular markers for Lung Adenocarcinoma?

A

EGFR
Ros1
ALK
Kras
BRAF
MET
PET
PDL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What lung molecular markers are raised in Lung adenocarcinoma in NON SMOKERS?

A

EGFR
Ros1
ALK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What lung adenocarcinoma marker is elevated in SMOKERs?

A

Kras

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What type of molecules are the lung molecular markers?

A

Oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the only marker tested in squamous cell carcinoma?

A

PDL1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What ethnicity is the mutation of the EGFR oncogene most common in as a lung molecular marker?

A

Asian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most frequent mutation causing the oncogene EGFR to be present as a lung molecular marker?

A

Deletion in Exon 19 of Ch7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens as a result of EGFR oncogene being present as a lung molecular marker?

A

It results in cell differentiation and proliferation, angiogenesis etc..

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What chemotherapeutic drug can be given to treat patients with lung adenocarcinoma that have the EGFR lung molecular marker present?

What type of drug is this?

Why does this work?

A

Gefitinib

An anti EGFR TKI (Tyrosine Kinase Inhibitor)

EGFR is a Receptor Tyrosine Kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the downside to using Gefitinib to treat Adenocarcinoma of lungs with EGFR present?

A

Drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a lung molecular marker that is commonly seen in young never smokers that is an insulin receptor subfamily of RTK?

A

ALK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does ALK do as an oncogene?

A

Signals cell proliferation and survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What drug can be used to treat lung carcinoma with the lung marker ALK present?

What type of drug is this?

What is the worry/downside of this drug?

A

Crizotinib

ATP kinase inhibitor

Drug resistance

18
Q

If a lung adenocarcinoma is positive for ROS1 molecular marker, what drug can be used?

What other molecular marker is this drug used for?

A

Crizotinib

ALK

19
Q

What is the main molecular marker seen in lung adenocarcinoma of smokers?

A

KRAS

20
Q

What is mutated in a lung adenocarcinoma with the molecular marker BRAF?

A

V600E mutation

21
Q

What type of drugs can be used to treat lung adenocarcinoma with BRAF present?

What are 2 examples of these drugs?

A

Anti BRAF drugs

Dabrafenib and Trametinib

22
Q

What are the Tumour Suppressor gene mutations that are common to Small cell carcinoma?

A

RB1 and myc mutation

23
Q

What is a tumour suppressor that is commonly mutated in both small cell and non-squamous cell carcinoma?

A

p53 mutations

24
Q

How do Tumour Cells use PDL1/PD1 to their advantage?

A

They use it to evade the immune response

Tumour cells make
PDL1 (Programmed Death Ligand 1)
PDL1 binds to the PD1 receptors on the T cells NOT allowing the T cells to recognise the cancer cell

25
Q

What immunotherapy drugs act against the PD1 receptor on the T cells preventing PDL1 from binding preventing it from suppressing T cells action against cancer cells?

A

Nivolumab or Pembrolizumab

26
Q

What immunotherapy drugs act against the PDL1 ligand, so nothing can bind to the PD1 receptor?

A

Atezolizumab and Duralumba

27
Q

What is the problem with using Nivolumab/Pembrolizumab (against PD1 receptor) or Atezolizumab and Duralumba (against PDL1 ligand) as an immunotherapy against cancers?

A

Unable to predict treatment efficacy and side effects

28
Q

What are some examples of growth factors produced by cancers?

A

PDGF (Platelet derived growth factor) - angiogenesis, stromal proliferation

TGF beta (transforming growth factor) - angiogenesis , interaction with lymphocytes and macrophages

29
Q

What is EGFR?

Where is it expressed?

What condition is it over expressed in?

A

Tyrosine kinase receptor which is a growth factor receptor

Epithelial cells

Amplified and overexpressed in lung squamous cell carcinoma, Adenocarcinoma and breast cancer

30
Q

What are some anti EGFR drugs?

A

Afatinib
Gefitinib
Erlotinib

31
Q

What is a lobectomy of the lung?

A

Diseased lobe of the lung is removed

32
Q

Histologically, how does a melanoma appear?

A

Brown cells
Pleomorphism
Increased nuclear to cytoplasmic ratio
Mitoses

33
Q

What molecular marker is looked for in melanoma?

A

BRAF (V600E mutation)

34
Q

What is a mutated V600E gene and affected lymph node indicative of?

A

Stage IV melanoma

35
Q

What pathway gets activated in melanoma as a result of BRAF present?

A

Activation of MAPK (Mitogen Activated protein pathway)

36
Q

What are 2 systemic therapies of melanoma:
Target therapy?
Immunotherapy?

A

Target therapy = anti BRAF (very good)

Immunotherapy = PDL1 target

37
Q

What are 2 anti BRAF drugs that can be used as a target systemic therapy for melanoma?

A

Dabrafenib
Trametinib

38
Q

What is the downside to only using Dabrafenib or Trametinib to treat a melanoma?

A

Tumour resistance can develop on selective BRAF inhibitors when they’re alone

39
Q

What type of treatment is the first line treatment in patients with stage IV melanoma who are lacking BRAF mutations?

What drugs can be used for this?

How do they work?

A

Immunotherapy

Nivolumab
Pembrolizumab

Blocks the PD1 receptor preventing PDL1 from binding to it. This prevents PDL1 from preventing T cells from recognising cancer cells

40
Q

What mutations are targeted in Metastatic urothelial carcinoma?

A

PDL1

41
Q

What mutations are targeted in Head and Neck cancer metastasis?

A

PDL1

42
Q

What mutations are targeted in Colorectal cancer?

A

DNA mis match repair enzymes

Y1 - PP (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions